Working in both the public and private sectors, Jerry Cangelosi's research teams have generated 10 patents and over 80 publications in relevant areas including tuberculosis and related diseases, COVID-19, oral microbiology, water-borne pathogens, and healthcare-associated infections. These activities share strong emphases on translation and global health impact. In recent years he has led or co-led infectious disease studies in the United States, Bangladesh, South Africa, Uganda, and Kenya. Among the outputs are novel, non-invasive tuberculosis screening methods that are now in expanded clinical studies worldwide. In the Spring of 2020, amidst the first wave of the SARS-CoV-2 pandemic, his team helped demonstrate similarly non-invasive methods for COVID-19 screening. These methods received accelerated FDA clearance and have become widely implemented in the United States and throughout the world. Non-invasive screening for TB and COVID-19 could help to significantly reduce the global burdens of both diseases.
Dr. Cangelosi is Professor in the University of Washington Department of Environmental & Occupational Health Sciences (DEOHS) and adjunct professor in the departments of Global Health and Epidemiology. He teaches environmental health courses on environmental change, microbiomes and environmental pathogens. He also serves as the DEOHS representative on the UW School of Public Health Faculty Council.
Learn more about his research on his lab page: https://deohs.